NCT03691831 - A Study of A-101 Topical Solution for the Treatment of Common Warts | Biotech Hunter

Enrollment

502

Participants

Timeline

Start Date

September 13, 2018

Primary Completion Date

April 21, 2019

Study Completion Date

July 9, 2019

Conditions

Common Wart

Interventions

DRUG

Active

A-101 45% (hydrogen peroxide 45% topical solution)

OTHER

Vehicle

Vehicle solution containing isopropyl alcohol and water

Trial Locations (24)

14623

Aclaris Investigational Site, Rochester

15241

Aclaris Investigational Site, Upper Saint Clair

20850

Aclaris Investigational Site, Rockville

23507

Aclaris Investigational Site, Norfolk

24501

Aclaris Investigational Site, Lynchburg

27612

Aclaris Investigational Site, Raleigh

29621

Aclaris Investigational Site, Anderson

33134

Aclaris Investigational Site, Coral Gables

33155

Aclaris Investigational Site, Miami

37215

Aclaris Investigational Site, Nashville

37922

Aclaris Investigational Site, Knoxville

44122

Aclaris Investigational Site, Beachwood

47150

Aclaris Investigational Site, New Albany

64506

Aclaris Investigational Site, Saint Joseph

68144

Aclaris Investigational Site, Omaha

72916

Aclaris Investigational Site, Fort Smith

76011

Aclaris Investigational Site, Arlington

77004

Aclaris Investigational Site, Houston

77845

Aclaris Investigational Site, College Station

80210

Aclaris Investigational Site, Denver

85308

Aclaris Investigational Site, Glendale

92121

Aclaris Investigational Site, San Diego

92024-7700

Aclaris Investigational Site, Encinitas

02169

Aclaris Investigational Site, Quincy